Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,178.2
-9.7 (-0.30%)

 

  • STI Straits Times Index
    3,178.2
    -9.7 (-0.30%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,595.8
    -1.9 (-0.12%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,850.0
    352.8 (1.24%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,401.7
    5.2 (0.15%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,641.7
    -109.9 (-0.37%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,013.3
    85.9 (1.45%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 734.4M
  • Value: 441.9M
  • Rise: 130
  • Fall: 134
  • Unch: 507

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.102+0.002
Sembcorp Marine0.198-0.002
CWX Global0.005+0.001
MM2 Asia0.059-0.002
Spackman0.007-
Japfa0.925-0.015
Golden Agri-Res0.215+0.005
Anchor Resources0.031+0.002
Ntegrator Intl0.013+0.001
Aspen0.255+0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,996.1 +146.1
HSI 28,850.0 +352.8
HSCEI 10,997.3 +146.8
Jakarta 6,013.3 +85.9
Nikkei 225 29,671.7 -79.9
SSE Comp 3,401.7 +5.2
Shanghai A 3,565.5 +5.5
Shanghai B 245.2 +0.4
KOSPI 3,179.9 +10.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AVECHO BIOTECHNOLOGY LTD AVECHO BIOTECHNOLOGY
Updated on 13 Apr 2021 (End of trading day)
Last (AUD): 0.021 Change: -0.001 High: 0.025 Remarks: -
Change (%): -4.55 Low: 0.021
Open 0.025 Yesterday's Close 0.022000000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 17,459,930 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.00144 Trailing EPS (AUD) e -0.00144 NAV (AUD) b 0.0015
PE a - Trailing PE f - Price / NAV b 14.0000
Dividend (AUD) d - Cash In Hand (AUD) g 0.0010 Issued & Paid-up Shares c 1,828,890,000
Dividend Yield (%) d - Price / Cash In Hand g 21.000 Treasury Shares h -
Beta - 75 Daysi -1.934 R-Squared - 75 Days(%)i 1.54 Market Cap (M) 38.407
Beta - 500 Daysi -0.004 R-Squared - 500 Days (%)i - Enterprise Value (M) 36.700
Piotroski F Score 0 Exchange Code AVE Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 124.77 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 27 May 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AVECHO BIOTECHNOLOGY LTD ASX 38.407 - - 14.0000 -
Industry Biotechnology ASX 3,322.033 46.334 38.022 10.7761 1.031
Local Peer CSL LTD ASX 120,452.059 38.406 31.650 11.3985 1.109
Local Peer POLYNOVO LIMITED ASX 1,951.095 - - 88.5886 -
Local Peer MESOBLAST LTD ASX 1,464.735 - - 2.1789 -
Local Peer TELIX PHARMACEUTIC ASX 1,136.747 - - 14.3875 -
Local Peer IMUGENE LIMITED ASX 810.164 - - 12.8788 -
Local Peer OPTHEA LIMITED ASX 544.083 - - 2.7538 -
Local Peer ANTEOTECH LIMITED ASX 552.842 - - 89.3939 -
Local Peer IMMUTEP LTD ASX 302.562 - - 4.9834 -
Local Peer NEXT SCIENCE LTD ASX 279.649 - - 11.4105 -
Local Peer KAZIA THERAPEUTICS LIMITED ASX 216.457 - - 6.8318 -
Local Peer BIONOMICS LTD ASX 190.701 - - 11.8750 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 165.239 - - 6.8270 -
Other Local Peers LEAF RESOURCES LTD (ASX), CHIMERIC THERAPEUTICS LTD (ASX), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), MEMPHASYS LTD (ASX), PATRYS LIMITED (ASX), ADALTA LTD (ASX), BIOTRON (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), CRYOSITE (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 143,921.710 19.813 19.813 15.2962 2.572
Global Peer GILEAD SCIENCES INC NASDAQ 81,540.774 662.955 662.933 4.4798 4.183
Global Peer ILLUMINA INC NASDAQ 58,819.585 89.664 89.664 12.5308 -
Global Peer MODERNA INC NASDAQ 59,910.948 - - 23.3900 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,889.807 20.611 20.611 6.4339 -
Global Peer WUXI BIO HKEx 437,226.136 230.385 230.387 17.9323 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 51,106.235 14.547 14.547 4.6354 -
Global Peer BIOGEN INC NASDAQ 40,076.235 10.018 10.018 3.7453 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 33,962.185 56.285 56.285 2.9149 -
Global Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 31,310.782 1,807.333 1,807.226 18.6538 -
Other Global Peers BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SEAGEN INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), SINO BIOPHARM (HKEx), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ZAI LAB-SB (HKEx), NEUROCRINE BIOSCIENCES INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), EXELIXIS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), JOINN (HKEx), INTELLIA THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ARENA PHARMACEUTICALS INC (NASDAQ), GENSCRIPT BIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ALKERMES PLC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), INSTIL BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), 3SBIO (HKEx), XENCOR INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), MYRIAD GENETICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), NUVATION BIO INC (NYSE), RUBIUS THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), MACROGENICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VIVA BIOTECH (HKEx), LUMINEX CORP(DEL) (NASDAQ), CYTOKINETICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIOATLA INC (NASDAQ), JW THERAP-B (HKEx), JACOBIO-B (HKEx), AURINIA PHARMACEUTICALS INC (NASDAQ), KINTOR PHARMA-B (HKEx), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), PRELUDE THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), UNIQURE N.V. (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), REGENXBIO INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), MIMEDX GROUP INC (NASDAQ), HAOHAI BIOTEC (HKEx), REPLIMUNE GROUP INC (NASDAQ), ALPHAMAB-B (HKEx), ALECTOR INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), FRONTAGE (HKEx), OCUGEN INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), AFFIMED N V (NASDAQ), NKARTA INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), VAXCYTE INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ASCENTAGE-B (HKEx), RHYTHM PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), JHBP-B (HKEx), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), CORTEXYME INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), HUMANIGEN INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), MERUS B V (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), INHIBRX INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), CHIMERIX INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), ARDELYX INC (NASDAQ), COMPUGEN (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), KADMON HLDGS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ATHIRA PHARMA INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), VAXART INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ANAPTYSBIO INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SINOMAB BIO-B (HKEx), RAPT THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), AKOUOS INC (NASDAQ), XBIOTECH INC (NASDAQ), DPHARMA (Bursa), PRECISION BIOSCIENCES INC (NASDAQ), AVROBIO INC (NASDAQ), ALTIMMUNE INC (NASDAQ), LEE'S PHARM (HKEx), SINOVAC BIOTECH LTD (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VERASTEM INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ATRECA INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), ADICET BIO INC (NASDAQ), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), SESEN BIO INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), PUMA BIOTECHNOLOGY INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), SPRUCE BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), BELLUS HEALTH INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ONCORUS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IMMUNOME INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), TREVENA INC (NASDAQ), NANOVIRICIDES INC (NYSE American), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MEDICINOVA INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIOVIE INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), INMUNE BIO INC (NASDAQ), ENZO BIOCHEM INC (NYSE), AXCELLA HEALTH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), BIOMX INC (NYSE American), CEL-SCI CORP (NYSE American), X4 PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), LONGEVERON INC (NASDAQ), SYNLOGIC INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), METACRINE INC (NASDAQ), ORGENESIS INC (NASDAQ), IBIO INC (NYSE American), BRAINSTROM CELL THERAPEUTICS (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), VASCULAR BIOGENICS LTD (NASDAQ), ARAVIVE INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), LUMOS PHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), CLEVELAND BIOLABS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), AIKIDO PHARMA INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), UNI-BIO GROUP (HKEx), SYNTHETIC BIOLOGICS INC (NYSE American), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), ADVAXIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), BIOCARDIA INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), PULMATRIX INCORPORATED (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ADITX THERAPEUTICS INC (NASDAQ), HISTOGEN INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ORAGENICS INC (NYSE American), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), PRECIPIO INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), Suntar Eco-City (SGX), GEOVAX LABS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HAO WEN HLDGS (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.001
-4.55 %
10 Days --0.001
-4.55 %
20 Days --0.002
-8.70 %
Medium Term Return 3 Months --0.005
-19.23 %
6 Months -+0.014
+200.00 %
1 Year -+0.016
+320.00 %
Annualised Return Annualised --
+320.00 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.004 - 0.045 Change From 1 Year Low +0.017 % Change From 1 Year Low (%) +425.00
Change From 1 Year High -0.024 % Change From 1 Year High (%) -53.33
2 Years Range 0.002 - 0.045 Change From 2 Years Low +0.019 % Change From 2 Years Low (%) +950.00
Change From 2 Years High -0.024 % Change From 2 Years High (%) -53.33
5 Years Range 0.002 - 0.045 Change From 5 Years Low +0.019 % Change From 5 Years Low (%) +950.00
Change From 5 Years High -0.024 % Change From 5 Years High (%) -53.33
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. It operates through the following business segments: Production and Personal Care; Human Health; and All Other. The Production and Personal Care segment manufactures and sells TPM and Vital ET. The Human Health segment covers delivery of drugs through gels, injectables, and patches. The All Other segments involves the BioElixia division. The company was founded on June 19, 1992 and is headquartered in Clayton, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
13 Apr 2021 0.025 0.025 0.021 0.021 17,459,930 -
12 Apr 2021 0.023 0.024 0.022 0.022 3,932,314 -
09 Apr 2021 0.021 0.025 0.021 0.023 12,501,530 -
08 Apr 2021 0.021 0.022 0.021 0.021 2,134,248 -
07 Apr 2021 0.023 0.023 0.022 0.022 1,178,791 -
06 Apr 2021 0.022 0.023 0.022 0.022 4,348,870 -
01 Apr 2021 0.023 0.023 0.022 0.022 2,251,584 -
31 Mar 2021 0.022 0.022 0.022 0.022 1,442,313 -
30 Mar 2021 0.022 0.023 0.022 0.022 2,433,095 -
29 Mar 2021 0.023 0.023 0.022 0.022 1,608,543 -
26 Mar 2021 0.022 0.024 0.022 0.023 2,725,558 -
25 Mar 2021 0.023 0.023 0.021 0.022 1,771,358 -
24 Mar 2021 0.023 0.023 0.021 0.022 2,352,690 -
23 Mar 2021 0.024 0.025 0.022 0.022 10,330,240 -
22 Mar 2021 0.022 0.026 0.022 0.024 7,950,870 -
19 Mar 2021 0.023 0.023 0.022 0.022 2,725,187 -
18 Mar 2021 0.022 0.023 0.022 0.023 1,356,356 -
17 Mar 2021 0.023 0.023 0.022 0.022 1,940,258 -
16 Mar 2021 0.023 0.023 0.023 0.023 620,681 -
15 Mar 2021 0.023 0.023 0.023 0.023 3,635,021 -
12 Mar 2021 0.020 0.025 0.020 0.022 11,816,080 -
11 Mar 2021 0.020 0.020 0.020 0.020 1,290,924 -
Summary
Current 2 Weeks
(29 Mar 2021 to 13 Apr 2021)
0.023 0.025 0.021 0.021 49,291,218 -
Previous 2 Weeks
(15 Mar 2021 to 26 Mar 2021)
0.023 0.025 0.021 0.023 35,408,219 -
4 Weeks from
(15 Feb 2021 to 12 Mar 2021)
0.027 0.027 0.021 0.022 72,737,033 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.